2003

Establishment of New DRG 535 is Milestone in Advancement of Heart Failure Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...

Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an...

The CONTAK RENEWAL TR 2 Implantable Cardiac Resynchronization Therapy Pacemaker Offers Market-leading Diagnostics and Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:...

New Device Captures Emboli Released During Carotid Stenting Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

Results Presented at American Association of Thoracic Surgeon''s 83rd Annual Meeting Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...

Strategic Alliance Aimed at Expanding Options for the Treatment of Sleep-Disordered Breathing Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham, Advisor to the President, has elected...

Worldwide Implantable Defibrillator Revenue Growth of 72 Percent Changes Product Mix Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE:...